Literature DB >> 20473789

PI3K signaling in neutrophils.

Phillip T Hawkins1, Len R Stephens, Sabine Suire, Michael Wilson.   

Abstract

PI3Ks play important roles in the signaling pathways used by a wide variety of cell surface receptors on neutrophils. Class IB PI3K plays a major role in the initial generation of PtdIns(3,4,5)P₃ by Gi-coupled G-protein coupled receptors (GPCRs) (e.g., receptors for fMLP, C5a, LTB₄). Class IA PI3Ks generate PtdIns(3,4,5)P₃ downstream of receptors which directly or indirectly couple to protein tyrosine kinases such as integrins, FcγRs, cytokine receptors, and GPCRs. The PtdIns(3,4,5)P₃ made by Class I PI3Ks regulates the activity of several different effector proteins, many of which are plasma membrane GEFs or GAPs for small GTPases. Class III PI3K generates PtdIns(3)P in the phagosome membrane and plays an important role in efficient assembly of the NADPH oxidase at this location. Much still remains to be discovered about the molecular details that govern activation of PI3Ks and the mechanisms by which these enzymes regulate complex cellular processes, such as neutrophil spreading, chemotaxis, phagocytosis, and killing of pathogens. However, it is clear from recent use of transgenic mouse models and isoform-selective PI3K inhibitors that these pathways are important in regulating neutrophil recruitment to sites of infection and damage in vivo. Thus, PI3K pathways may present novel opportunities for selective inhibition in some inflammatory pathologies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20473789     DOI: 10.1007/82_2010_40

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  42 in total

Review 1.  Emerging mechanisms of neutrophil recruitment across endothelium.

Authors:  Marcie R Williams; Verónica Azcutia; Gail Newton; Pilar Alcaide; Francis W Luscinskas
Journal:  Trends Immunol       Date:  2011-08-11       Impact factor: 16.687

Review 2.  Phosphatidylinositol-3,4,5-triphosphate and cellular signaling: implications for obesity and diabetes.

Authors:  Prasenjit Manna; Sushil K Jain
Journal:  Cell Physiol Biochem       Date:  2015-02-11

Review 3.  Interplay between phosphoinositide lipids and calcium signals at the leading edge of chemotaxing ameboid cells.

Authors:  Joseph J Falke; Brian P Ziemba
Journal:  Chem Phys Lipids       Date:  2014-01-19       Impact factor: 3.329

Review 4.  Phosphoinositide 3-Kinase in Asthma: Novel Roles and Therapeutic Approaches.

Authors:  Edwin J Yoo; Christie A Ojiaku; Krishna Sunder; Reynold A Panettieri
Journal:  Am J Respir Cell Mol Biol       Date:  2017-06       Impact factor: 6.914

Review 5.  Cross-talk between Rho GTPases and PI3K in the neutrophil.

Authors:  Barry McCormick; Julia Y Chu; Sonja Vermeren
Journal:  Small GTPases       Date:  2017-04-17

6.  Pseudomonas aeruginosa Effector ExoS Inhibits ROS Production in Human Neutrophils.

Authors:  Chairut Vareechon; Stephanie Elizabeth Zmina; Mausita Karmakar; Eric Pearlman; Arne Rietsch
Journal:  Cell Host Microbe       Date:  2017-05-10       Impact factor: 21.023

Review 7.  PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances.

Authors:  Lomon So; David A Fruman
Journal:  Biochem J       Date:  2012-03-15       Impact factor: 3.857

Review 8.  Pathophysiology and Treatments of Oxidative Injury in Ischemic Stroke: Focus on the Phagocytic NADPH Oxidase 2.

Authors:  Federico Carbone; Priscila Camillo Teixeira; Vincent Braunersreuther; François Mach; Nicolas Vuilleumier; Fabrizio Montecucco
Journal:  Antioxid Redox Signal       Date:  2014-04-22       Impact factor: 8.401

Review 9.  Classes of phosphoinositide 3-kinases at a glance.

Authors:  Steve Jean; Amy A Kiger
Journal:  J Cell Sci       Date:  2014-03-01       Impact factor: 5.285

Review 10.  Phosphatidylinositol 3-Kinase: A Link Between Inflammation and Pancreatic Cancer.

Authors:  Chiara Birtolo; Vay Liang W Go; Andrzej Ptasznik; Guido Eibl; Stephen J Pandol
Journal:  Pancreas       Date:  2016-01       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.